Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis
阿法替尼在EGFR T790M阴性的人口腔癌中具有抗肿瘤活性,其治疗靶点为mTOR/Mcl-1信号通路。
期刊:Cellular Oncology
影响因子:4.8
doi:10.1007/s13402-024-00962-6
Han, Jung-Min; Oh, Kyu-Young; Choi, Su-Jung; Lee, Won-Woo; Jin, Bo-Hwan; Kim, Ji-Hoon; Yu, Hyun-Ju; Kim, Ryan Jin Young; Yoon, Hye-Jung; Lee, Jae-Il; Hong, Seong-Doo; Cho, Sung-Dae